» Articles » PMID: 20110726

Prevalence of Polycystic Ovary Syndrome and Related Disorders in Mexican Women

Overview
Date 2010 Jan 30
PMID 20110726
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Polycystic ovary syndrome (PCOS) has been found to affect 4-8% of women of reproductive age; however, in Mexican-Americans a prevalence of 12.8% has been reported. This study determines the prevalence of PCOS in a sample of Mexican women.

Methods: This prospective cross-sectional study included 150 female Mexican volunteers aged 20-45 years. Menstrual cycles were recorded and hirsutism was graded. Pelvic ultrasound was performed and androgen levels were measured. PCOS was diagnosed by hyperandrogenism and/or hyperandrogenemia, and oligo-ovulation (NIH 1990 criteria), and also by 2 of 3 findings: oligo-ovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries (PCO) (Rotterdam 2003 criteria), excluding other disorders.

Results: Nine of the 150 women were diagnosed with PCOS, a prevalence of 6.0% (95% CI: 1.9-10.1%), according to NIH criteria. The ultrasound morphology added one patient to give ten PCOS patients, a prevalence of 6.6% (95% CI: 2.3-10.9%) according to Rotterdam criteria. All PCOS patients presented oligo-ovulation, 9 had hirsutism and 7 of them had acne. Eight of the 10 PCOS patients had morphologic characteristics of PCO.

Conclusion: The prevalence of PCOS in Mexican women is approximately 6.0%, similar to other populations, but lower than 12.8% reported in Mexican-American women.

Citing Articles

Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis.

Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S Arch Gynecol Obstet. 2024; 310(3):1303-1314.

PMID: 38922413 DOI: 10.1007/s00404-024-07607-x.


Polymorphism, along with Deletion of and Genes, Strongly Influences Female Infertility Risk.

Casteleiro Alves M, Almeida M, Oliani A, Breitenfeld L, Ramalhinho A Antioxidants (Basel). 2023; 12(4).

PMID: 37107315 PMC: 10135531. DOI: 10.3390/antiox12040940.


Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis.

Bharali M, Rajendran R, Goswami J, Singal K, Rajendran V Cureus. 2023; 14(12):e32351.

PMID: 36628015 PMC: 9826643. DOI: 10.7759/cureus.32351.


Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations.

Yasmin A, Roychoudhury S, Paul Choudhury A, Ahmed A, Dutta S, Mottola F Life (Basel). 2022; 12(12).

PMID: 36556340 PMC: 9785838. DOI: 10.3390/life12121974.


[Proinflammatory cytokines in polycystic ovarian syndrome].

Garcia-Saenz M, Ferreira-Hermosillo A, Lobaton-Ginsberg M Rev Med Inst Mex Seguro Soc. 2022; 60(5):569-576.

PMID: 36049035 PMC: 10396056.